Related Experiment Video
Updated: Jun 26, 2026
12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
Hypoglycaemia in residential care homes
Ahmed H Abdelhafiz1, Alan J Sinclair
1Department of Elderly Medicine, Rotherham General Hospital, Rotherham. ahmedhafiz@hotmail.com
Summary
Hypoglycaemia is a common issue for older adults with type 2 diabetes in care homes. This study highlights the challenges and complexities of managing this metabolic complication in this vulnerable population.
Area of Science:
- Gerontology
- Metabolic Medicine
- Clinical Pharmacy
Background:
- Older adults with type 2 diabetes are susceptible to hypoglycaemia, a frequent metabolic complication.
- Care home residents with diabetes represent a significant and understudied population.
- High levels of disability, dependency, and polypharmacy are common in care home settings.
Observation:
- Limited data exist on the prevalence of diabetes and its complications in care homes.
- Hypoglycaemia presents as both a treatment adverse reaction and a critical outcome measure.
- A case study illustrates the multifaceted causes and patient characteristics associated with hypoglycaemia.
Findings:
- Older individuals with type 2 diabetes in care homes experience frequent hypoglycaemia.
- Care home residents exhibit complex health profiles, including disability, dependency, and polypharmacy.
- The management of hypoglycaemia in this setting is intricate due to patient comorbidities and medication regimens.
Implications:
- Increased awareness and targeted interventions are needed for hypoglycaemia management in care homes.
- Further research is crucial to understand the prevalence and impact of diabetes complications in this population.
- Optimizing diabetes care in care homes can improve patient outcomes and reduce adverse events.
Related Concept Videos
01:26Hypoglycemia
Hypoglycemia is a blood glucose level below 70 mg/dL. It commonly occurs in individuals using insulin or insulin-secreting drugs, but may also arise in non-diabetic conditions. People with type 1 diabetes are at the highest risk because they depend on exogenous insulin. People with type 2 diabetes are also at risk, especially when treated with insulin or medications such as sulfonylureas, which increase insulin release regardless of blood glucose levels. It develops when insulin levels exceed...
01:15Hypoglycemia and Glucagon
Without prolonged fasting, healthy individuals maintain blood glucose levels above 3.5 mM due to a well-adapted neuroendocrine counterregulatory system that effectively prevents acute hypoglycemia, a potentially life-threatening condition. The primary clinical scenarios for hypoglycemia encompass diabetes treatment, inappropriate production of endogenous insulin or insulin-like substances by tumors, and the use of glucose-lowering agents in non-diabetic individuals. Notably, hypoglycemia in the...
01:29Hyperglycemia
Hyperglycemia is an abnormally high blood glucose level. It is diagnosed by fasting glucose ≥126 mg/dL, 2-hour oral glucose tolerance test (or OGTT) ≥200 mg/dL, random glucose ≥200 mg/dL with symptoms, or HbA1c ≥6.5%. However, HbA1c results may be unreliable in certain conditions, such as anemia or hemoglobinopathies, and the diagnosis should be confirmed unless classic symptoms are present. Postprandial hyperglycemia is typically considered significant when glucose levels exceed 180 mg/dL two...
01:19Type I Diabetes III: Clinical Manifestations
Type 1 diabetes mellitus typically presents with rapid-onset symptoms due to the body’s inability to utilize glucose in the absence of insulin. Since insulin is required for glucose uptake into cells, its deficiency leads to hyperglycemia and cellular energy deprivation, resulting in characteristic clinical features.Polyuria and PolydipsiaOne of the earliest, most prominent symptoms is polyuria (excessive urination). When blood glucose concentrations rise above the renal threshold, the kidneys...
01:14SBAR II: Application of SBAR
SBAR is an effective communication tool used by healthcare professionals to communicate patient information accurately. SBAR stands for Situation, Background, Assessment, and Recommendation. For a better understanding, an example is given below.
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
SBAR Report from a Nurse to a Health Care Provider
S: "Hello, Dr. Smith. This is Jane, RN, from the Med Surg unit. I am calling to tell you about Ms. White in Room 210, who is experiencing increased pain and redness at her incision site. Her recent...
01:06Oral Hypoglycemic Agents: Glinides
Repaglinide (Prandin) and Nateglinide (Starlix), known as glinides, are oral insulin secretagogues that stimulate insulin release from pancreatic β cells by closing the ATP-sensitive potassium channels (KATP channel). Repaglinide controls insulin release from pancreatic β cells by managing potassium efflux. It shares two binding sites with sulfonylureas and also has a unique site, indicating overlapping mechanisms of action. With a rapid onset and a 4-7 hour duration, it effectively manages...